New Treatment Option for Patients at Risk of Sudden Cardiac Arrest
Published date : 29 October 2012
Article date : 29 October 2012
The Scaramento Bee reports on the FDA's approval of what they describe as 'the world's first subcutaneous implantable defibrillator' providing a new treatment option for patients who are at risk of sudden cardiac arrest.
The S-ICD System, manufactured by Boston Scientific, has two main components. One is a pulse generator which powers the system, monitors heart activity and delivers a shock, if required. The second main component is an electrode that enables the device to sense the heart rhythm and deliver shocks when necessary. Both are implanted just under the skin, providing protection without touching the heart and reliable defibrillation without transvenous wires.
The Bluhm Cardiovascular Institute is one of the first ten places to implant in the US.
Source: The Sacramento Bee (www.sacbee.com), 25 October 2012
Read the original article here.
